Amgen Inc (AMGN) 169.10 $AMGN Final Glance:

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 7:05 PM

Amgen Inc (AMGN) 169.10 $AMGN

Final Glance: Biotechnology companies
AP - 51 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 6 mins ago
Pfizer Inc.'s (PFE) phase III study on inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia (ALL) met the first primary endpoint.
BIIB: 423.57 (+1.46), PFE: 34.93 (+0.04), HZNP: 30.96 (+0.10), AMGN: 169.10 (+0.64)

Stocks Strengthen; Tesla Motors Rises On Battery News
at Investor's Business Daily - Wed Apr 22, 2:04PM CDT
Stocks strengthened in mixed volume going into the final hour of trading Wednesday. The Nasdaq and the Dow Jones industrial average each rose 0.5%, while the S&P 500 gained 0.6%. Volume was tracking higher on the NYSE and lighter on the Nasdaq in the...
TSLA: 219.44 (+10.03), V: 68.01 (+2.66), FB: 84.63 (+1.01), CMG: 641.23 (-51.29), ILMN: 190.04 (-9.27), AMGN: 169.10 (+0.64), WAB: 98.61 (+2.84), MA: 91.20 (+3.43)

Alnylam Reports Positive Patisiran Results, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 1:02PM CDT
Alnylam Pharmaceuticals (ALNY) announced encouraging results from its phase II study on patisiran.
BIIB: 423.57 (+1.46), ALNY: 118.00 (-2.70), AMGN: 169.10 (+0.64), SNY: 51.59 (+0.03)

Midday Glance: Biotechnology companies
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 22, 12:21PM CDT
Amgen's (AMGN) first quarter 2015 results were impressive and the company raised its earnings outlook for the year.
BIIB: 423.57 (+1.46), ALNY: 118.00 (-2.70), GILD: 104.18 (-1.02), MDCO: 27.84 (+0.25), AMGN: 169.10 (+0.64), AMPE: 2.89 (+0.20), ABBV: 64.52 (+0.91), ATHX: 1.34 (+0.01)

Stocks Mildly Higher; China Nods To Visa, MasterCard
at Investor's Business Daily - Wed Apr 22, 10:53AM CDT
Stocks had trouble finding direction during the morning but were mildly higher going into the noon hour as a mixed bag of earnings reports dominated the action. The Nasdaq rose less than 0.1%; the S&P 500 and the Dow Jones industrial average gained...
V: 68.01 (+2.66), CMG: 641.23 (-51.29), ILMN: 190.04 (-9.27), AMGN: 169.10 (+0.64), MA: 91.20 (+3.43), YUM: 84.04 (+3.19)

Today's Market: Tech And Biotech Stocks In The News
Matthew Smith - at Seeking Alpha - Wed Apr 22, 10:08AM CDT

YHOO: 43.97 (-0.52), FB: 84.63 (+1.01), ALU: 4.12 (+0.09), BUNT: 52.95 (-1.24), AMGN: 169.10 (+0.64), TWTR: 51.73 (+0.41), MSFT: 42.99 (+0.36), NOK: 8.00 (+0.16), BUNL: 27.69 (-0.14), BABA: 82.05 (-0.37)

Early Glance: Biotechnology companies
AP - Wed Apr 22, 9:25AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Amgen Earnings Reveals Ugly Truth About Drug Pricing and Sales 'Growth'
at The Street - Wed Apr 22, 9:18AM CDT
It's common for drug companies to raise the price of their existing products once or twice per year, every year. The price increases far outpace the rate of inflation.
BIIB: 423.57 (+1.46), GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Stock Market News for April 22, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 9:10AM CDT
Benchmarks finished Tuesday’s trading session mostly lower following a mixed bag of earnings reports
VRTX: 132.85 (+0.65), UTX: 116.96 (+0.01), KMB: 111.85 (-1.30), MYL: 72.40 (-1.67), AMGN: 169.10 (+0.64), XOM: 87.46 (+0.58), SLB: 92.16 (+0.87), RIG: 16.85 (-0.18), IBM: 165.36 (+1.10), EOG: 97.70 (+1.11), DD: 71.44 (+0.75), TEVA: 63.01 (-1.15), CVX: 109.50 (-0.23), REGN: 472.63 (+9.41), TRV: 102.02 (+0.14)

Amgen (AMGN) Crosses Pivot Point Resistance at $169.20
Comtex SmarTrend(R) - Wed Apr 22, 9:08AM CDT
Shares of Amgen (NASDAQ:AMGN) opened today above their pivot of $168.14 and have already reached the first level of resistance at $169.20. Should the shares continue to rise, the resistance pivots of $169.95 and $171.76 will be of interest.
AMGN: 169.10 (+0.64)

Actelion (ALIOF) Beats Q1 Earnings & Revenue Expectations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 8:50AM CDT
Actelion Ltd. (ALIOF) reported first-quarter 2015 earnings of $1.57 per ADR beating the Zacks Consensus Estimate of $1.28 per ADR.
BIIB: 423.57 (+1.46), HZNP: 30.96 (+0.10), AMGN: 169.10 (+0.64)

Critical Alerts For Celgene, Rambus, Mylan, Amgen and Zoetis Released By InvestorsObserver
PR Newswire - Wed Apr 22, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for CELG, RMBS, MYL, AMGN and ZTS.
ZTS: 47.03 (-0.51), AMGN: 169.10 (+0.64), MYL: 72.40 (-1.67), RMBS: 14.40 (+0.22), CELG: 115.54 (+0.72)

A Discussion Of Amgen's Q1 Results, With Updates On Its Pipeline
DoctoRx - at Seeking Alpha - Wed Apr 22, 8:28AM CDT

PFE: 34.93 (+0.04), AMGN: 169.10 (+0.64), LLY: 72.30 (+0.09), BMY: 66.60 (-0.21), SNY: 51.59 (+0.03), REGN: 472.63 (+9.41), HSP: 87.80 (+0.04), CELG: 115.54 (+0.72)

Amgen Beats on Q1 Earnings & Revenues, Ups Earnings View - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 22, 8:15AM CDT
Amgen (AMGN) started 2015 on a strong note with earnings and revenues surpassing expectations.
BIIB: 423.57 (+1.46), OSIR: 16.35 (-0.10), AMGN: 169.10 (+0.64), NVS: 103.45 (-0.62)

Amgen (AMGN) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Wed Apr 22, 7:29AM CDT
The following Amgen (AMGN) conference call took place on April 21, 2015, 05:00 PM ET. This is a transcript of that earnings call:
AMGN: 169.10 (+0.64)

'Fast Money' Recap: How to Trade Yahoo!, Chipotle After Earnings
at The Street - Wed Apr 22, 4:00AM CDT
The trading panel looked at Yahoo!'s challenges, what to do with Yum! Brands and whether to buy Amgen.
JACK: 91.32 (-0.27), YHOO: 43.97 (-0.52), CMG: 641.23 (-51.29), MCD: 97.84 (+2.97), LOCO: 28.22 (-0.34), DD: 71.44 (+0.75), AMGN: 169.10 (+0.64), GOOGL: 549.18 (+6.26), YUM: 84.04 (+3.19), GSG: 20.72 (+0.02), BABA: 82.05 (-0.37)

Amgen's (AMGN) CEO Bob Bradway on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Apr 21, 8:18PM CDT

AMGN: 169.10 (+0.64)

Amgen tops estimates with 51 percent spike in 1Q profit
By LINDA A. JOHNSON - AP - Tue Apr 21, 6:27PM CDT
TRENTON, N.J. (AP) — Amgen Inc. boosted its first-quarter profit by 51 percent, thanks to surging drug sales and ongoing cost cuts designed to free up cash for an unprecedented burst of new product launches.
1 Comment
AMGN: 169.10 (+0.64), REGN: 472.63 (+9.41)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Air Sealing First: Boosting Home Comfort & Efficiency

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Miranda Lambert Lights Up Red Kettle Campaign

By Logan Wright Updated Oct 25, 2026 Category News Views 158

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...